Prescribing patterns for antihypertensive drugs after the publication of the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) in Region Emilia Romagna (RER), Italy

被引：0
|
作者：
Maio, V [1 ]
Yuen, EJ [1 ]
Smith, KD [1 ]
Louis, DZ [1 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)64695-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A126 / A126
页数：1
相关论文
共 50 条
  • [31] Heart failure with preserved and impaired left ventricular systolic function in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Davis, Barry R.
    Simpson, Lara M.
    Black, Henry R.
    Cushman, Wililam C.
    Einhorn, Paula T.
    Farber, Michael A.
    Ford, Charles E.
    Levy, Daniel
    Massie, Barry M.
    Nawaz, Shah
    Nawaz, Shah
    CIRCULATION, 2006, 114 (18) : 571 - 571
  • [32] THE EFFECT OF RENAL FUNCTION ON INCIDENCE OF CONGESTIVE HEART FAILURE: THE ANTIHYPERTENSIVE AND LIPID-LOWERING TREATMENT TO PREVENT HEART ATTACK TRIAL (ALLHAT) STUDY
    Kholghi, Maedeh Khayyat
    Oparil, Suzanne
    Davis, Barry
    Tereshchenko, Larisa G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 752 - 752
  • [33] Relationship of 1 year hypokalemia incidence to clinical outcomes in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Alderman, Michael
    Calhoun, David
    Cushman, William
    Davis, Barry
    Eckfeldt, John
    Einhorn, Paula
    Ford, Charles
    Franklin, Stanley
    Furberg, Curt
    Ong, Stephen
    Oparil, Suzanne
    Papademetriou, Vasilios
    Piller, Linda
    Probstfield, Jeffrey
    CIRCULATION, 2006, 114 (18) : 576 - 576
  • [34] Follow-up specialists in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Contribution to study closeout
    Pressel, S
    Davis, B
    Blanton, J
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 116S - 117S
  • [35] Diuretic versus α-blocker as first-step antihypertensive therapy -: Final results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Alderman, MH
    HYPERTENSION, 2003, 42 (03) : 239 - 246
  • [36] Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia - Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
    Whelton, PK
    Barzilay, J
    Cushman, WC
    Davis, BR
    Iiamathi, E
    Kostis, JB
    Leenen, FHH
    Louis, GT
    Margolis, KL
    Mathis, DE
    Moloo, J
    Nwachuku, C
    Panebianco, D
    Parish, DC
    Pressel, S
    Simmons, DL
    Thadani, U
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) : 1401 - 1409
  • [37] Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Piller, Linda B.
    Baraniuk, Sarah
    Simpson, Lara M.
    Cushman, William C.
    Massie, Barry M.
    Einhorn, Paula T.
    Oparil, Suzanne
    Ford, Charles E.
    Graumlich, James F.
    Dart, Richard A.
    Parish, David C.
    Retta, Tamrat M.
    Cuyjet, Aloysius B.
    Jafri, Syed Z.
    Furberg, Curt D.
    Saklayen, Mohammad G.
    Thadani, Udho
    Probstfield, Jeffrey L.
    Davis, Barry R.
    CIRCULATION, 2011, 124 (17) : 1811 - U88
  • [38] Review of heart failure events in the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT): ALLHAT heart failure validation study
    Einhorn, P
    Davis, B
    Piller, L
    deLeon, B
    Simpson, L
    Kostis, J
    Levy, D
    Massie, B
    Nwachuku, C
    Black, H
    Cushman, W
    CIRCULATION, 2003, 108 (17) : 399 - 400
  • [39] Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, SL
    Davis, BR
    Wright, JT
    Geraci, TS
    Kingry, C
    Ford, CE
    Piller, LB
    Bettencourt, J
    Kimmel, B
    Lusk, C
    Parks, H
    Simpson, LM
    Nwachuku, C
    Furberg, CD
    CONTROLLED CLINICAL TRIALS, 2001, 22 (01): : 29 - 41
  • [40] Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome - Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Wright, Jackson T.
    Harris-Haywood, Sonja
    Pressel, Sara
    Barzilay, Joshua
    Bairnbridge, Charles
    Bareis, Charles J.
    Basile, Jan N.
    Black, Henry R.
    Dart, Richard
    Gupta, Alok K.
    Hamilton, Bruce P.
    Einhorn, Paula T.
    Haywood, L. Julian
    Jafri, Syed Z. A.
    Louis, Gail T.
    Whelton, Paul K.
    Scott, Cranford L.
    Sinnnons, Debra L.
    Stanford, Carol
    Davis, Barry R.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (02) : 207 - 217
12345